NPM-RAR binding to TRADD selectively inhibits caspase activation, while allowing activation of NFκB and JNK. Issue 12 (2nd December 2015)

• Record Type: Journal Article
• Authors: Chattopadhyay, Anuja; Abecassis, Irina; Redner, Robert L.
• Is Part Of: Leukemia & lymphoma. Volume 56:Issue 12(2015:Dec.)
• Page Start: 3401
• Page End: 3406
• Publication Date: 2015-12-02
• Subjects: NPM–RAR -- acute promyelocytic leukemia -- TNF -- TRADD -- NFκB -- JNK; Leukemia -- Periodicals; Lymphomas -- Periodicals; 616.99419
• DOI: 10.3109/10428194.2015.1023799
• Languages: English
• ISSNs: 1042-8194

Abstract

Abstract : The t(5;17) variant of acute promeylocytic leukemia (APL) expresses a fusion of nucleophosmin (NPM) with the retinoic acid receptor alpha (RARA). We have previously shown that NPM–RAR is a binding partner of the tumor necrosis factor (TNF) receptor type-I-associated DEATH domain protein, TRADD. Binding of TNF to its receptor, TNF-R, induces recruitment of TRADD, and subsequent recruitment of a cascade of proteins that ultimate activate caspase 3, nuclear factor κB (NFκB) and c-Jun N-terminal kinase (JNK). We have previously shown that NPM–RAR interaction with TRADD blocks TNF activation of caspase 3, caspase 8, poly(ADP-ribose) polymerase (PARP) cleavage and, ultimately, apoptosis. We now report that NPM–RAR expression is permissive for TNF activation of NFκB and JNK. We propose that inhibition of TNF activation of apoptosis, while preserving TNF activation of NFκB and JNK pathways that stimulate cell growth and survival, represents a novel mechanism through which NPM–RAR contributes to development of the leukemic phenotype.